Research Use Disclaimer Retatrutide (RETA-10) 112mg research peptide is intended strictly for laboratory research and analytical purposes only
While not a direct side effect, you may pass out if the medication leads to severe dehydration or dangerously low blood sugar
Assess your health and weight loss goals
Some individuals may experience mild side effects, such as: Temporary injection site irritation Mild digestive discomfort Short-term fatigue during adjustment At Arviv safety and effectiveness are our top priorities
Yes, you can switch from semaglutide to retatrutide, but its important to do so under the guidance of a healthcare professional
Unsurprisingly, the majority of innovators focus on the myostatin/activin signalling pathway given its pivotal role in controlling muscle growth, with assets targeting activin and myostatin accounting for 41% and 25% of the pipeline, respectively, or two-thirds collectively